NYSE:PLX
Protalix BioTherapeutics Inc Stock News
$1.18
-0.0300 (-2.48%)
At Close: Apr 25, 2024
Small Cap Alert: ToughBuilt Industries, Inc. (NASDAQ:TBLT), Protalix BioTherapeutics, Inc. (AMEX:PLX)
10:38am, Wednesday, 22'nd Dec 2021 Stock Equity
ToughBuilt Industries, Inc. (NASDAQ:TBLT) with the stream of 2.99% also noticed, India Protalix BioTherapeutics, Inc. (AMEX:PLX) encountered a rapid change of 1.56% in the last hour of Tuesdays trading session. The post Small Cap Alert: ToughBuilt Industries, Inc. (NASDAQ:TBLT), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Right Now
03:05pm, Tuesday, 21'st Dec 2021
5 penny stocks with high short interest to add to your watch list in December. The post Best Penny Stocks To Buy?
Hottest Stock Now: Senmiao Technology Limited (NASDAQ:AIHS), Protalix BioTherapeutics, Inc. (AMEX:PLX)
01:11am, Monday, 13'th Dec 2021 Stock Equity
Senmiao Technology Limited (NASDAQ:AIHS) with the stream of -2.88% also noticed, India Protalix BioTherapeutics, Inc. (AMEX:PLX) encountered a rapid change of 1.11% in the last hour of Fridays trading session. The post Hottest Stock Now: Senmiao Technology Limited (NASDAQ:AIHS), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX) Shares Bought by Morgan Stanley
09:16am, Sunday, 12'th Dec 2021 Dakota Financial News
Morgan Stanley raised its stake in Protalix BioTherapeutics, Inc. (NYSEAMERICAN:PLX) by 3,723,538.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,861,819 shares of the companys stock after acquiring an additional 1,861,769 shares during the period. Morgan Stanleys holdings in Protalix BioTherapeutics []
Investors must not feel shy to buy this Stock: Las Vegas Sands Corp. (NYSE:LVS), Protalix BioTherapeutics, Inc. (AMEX:PLX)
04:11am, Monday, 29'th Nov 2021 Stock Equity
Las Vegas Sands Corp. (LVS) with the stream of -5.35% also noticed, India Protalix BioTherapeutics, Inc. (PLX) encountered a rapid change of -1.00% in the last hour of trading session. The post Investors must not feel shy to buy this Stock: Las Vegas Sands Corp. (NYSE:LVS), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Protalix BioTherapeutics Inc. (AMEX: PLX): Whats Next In 2021?
07:00pm, Thursday, 25'th Nov 2021 Stocks Register
Protalix BioTherapeutics Inc. (AMEX:PLX) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 6.10% to the previous days close as strong demand from buyers drove the stock to $1.00. Actively observing the price movement in the last trading, the stock closed the session at $0.94, falling within a range of $0.92 Protalix BioTherapeutics Inc. (AMEX: PLX): Whats Next In 2021? Read More »
Protalix BioTherapeutics Inc (PLX): Price Now Near $0.95; Daily Chart Shows Downtrend on 100 Day Basis
03:19pm, Tuesday, 23'rd Nov 2021 ETF Daily News
The moving averages on the daily timeframe suggest a bearishness in price, as the 20, 50, 100 and 200 are all in a bearish alignment -- meaning the shorter duration moving averages are below the longer duration averages, implying a stable downward trend. The post Protalix BioTherapeutics Inc (PLX): Price Now Near $0.95; Daily Chart Shows Downtrend on 100 Day Basis appeared first on ETF Daily News .
Traders cant blink on this: Recon Technology, Ltd. (NASDAQ:RCON), Protalix BioTherapeutics, Inc. (AMEX:PLX)
11:09am, Tuesday, 23'rd Nov 2021 Stock Equity
Flora Growth Corp. (FLGC) with the stream of 0.92% also noticed, India Golden Minerals Company (AUMN) encountered a rapid change of 0.00% in the last hour of Mondays trading session. The post Traders cant blink on this: Recon Technology, Ltd. (NASDAQ:RCON), Protalix BioTherapeutics, Inc. (AMEX:PLX) appeared first on Stocks Equity .
Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2021 Results - Earnings Call Transcript
06:42pm, Monday, 15'th Nov 2021 Seeking AlphaProtalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2021 Results - Earnings Call Transcript
01:42pm, Monday, 15'th Nov 2021
Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q3 2021 Results - Earnings Call Transcript
CARMIEL, Israel and BOSTON, Oct. 15, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and comme
PLX Stock: Why It Fell Today
10:25am, Monday, 11'th Oct 2021
The stock price of Protalix Biotherapeutics Inc (NYSEAMERICAN: PLX) fell by over 8% during intraday trading today. This is why it happened.
Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease
06:50am, Monday, 11'th Oct 2021
CARMIEL, Israel and BOSTON, Oct. 11, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and comme
Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2021 Results - Earnings Call Transcript
02:27pm, Monday, 16'th Aug 2021
Protalix BioTherapeutics, Inc. (PLX) CEO Dror Bashan on Q1 2021 Results - Earnings Call Transcript
Protalix BioTherapeutics Reports Second Quarter 2021 Financial Results and Financial and Business Update
06:50am, Monday, 16'th Aug 2021
CARMIEL, Israel, Aug. 16, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization